DESPATCH: DElivering Stroke Prevention for Atrial Fibrillation: assisting evidence-based CHoice in primary care [ 2007 - 2009 ]

Research Grant

Researchers: Dr Melina Gattellari (Principal investigator) ,  A/Pr John Worthington ,  A/Pr Obioha Ukoumunne ,  Prof Dominic Leung ,  Prof Jeremy Grimshaw
View all 6 related researchers

Brief description Non-valvular atrial fibrillation (NVAF) is a common heart condition associated with a major risk of fatal and disabling stroke. Inexpensive anticoagulant medication has been proven to reduce all-causes of death and stroke in patients with NVAF. Anticoagulant treatment for NVAF is substantially under-used resulting in avoidable patient deaths and disabling stroke. The National Institute of Clinical Studies of Australia summarised the large, unrealised benefit of anticoagulation, stating that 'each year, for every 1000 patients with NVAF given anticoagulants, we can assume that about 25 fewer people will experience a stroke and 12 fewer will die from a stroke than would be the case if they were not given them'. Despite this realisation, there is a lack of evidence to support any strategy to improve the care of patients with NVAF. This study seeks to optimise the management of NVAF in general practice. The DESPATCH study will employ a rigorous randomised design to evaluate an innovative educational intervention intended to overcome barriers to the best management of NVAF. If successful, DESPATCH will inform policy and practice aimed at overcoming barriers to best practice for the large and growing number of people with NVAF to reduce the risk of fatal and disabling stroke.

Funding Amount $AUD 561,447.10

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant